In this article, we will discuss Durvalumab (Warnings-31). So, let’s get started.
Gastrointestinal: Pancreatitis includes increases in serum amylase and lipase levels, gastritis, and duodenitis.
In this article we will discuss Durvalumab (Warnings-31)